This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2015 Feb;14(2):127-8.

doi: 10.1016/S1474-4422(14)70326-6. Epub 2014 Dec 30.

Prevention of cardiomyopathy in Duchenne muscular dystrophy

Corrado Angelini¹

Affiliations

PMID: 25554403
DOI: 10.1016/S1474-4422(14)70326-6

Comment

Prevention of cardiomyopathy in Duchenne muscular dystrophy

Corrado Angelini. Lancet Neurol. 2015 Feb.

. 2015 Feb;14(2):127-8.

doi: 10.1016/S1474-4422(14)70326-6. Epub 2014 Dec 30.

Author

Corrado Angelini¹

Affiliation

¹ IRCCS Fondazione San Camillo Hospital, Venice, Italy. Electronic address: corrado.angelini@ospedalesancamillo.net.

PMID: 25554403
DOI: 10.1016/S1474-4422(14)70326-6

No abstract available

PubMed Disclaimer

Comment on

Eplerenone for early cardiomyopathy in Duchenne muscular dystrophy: a randomised, double-blind, placebo-controlled trial.
Raman SV, Hor KN, Mazur W, Halnon NJ, Kissel JT, He X, Tran T, Smart S, McCarthy B, Taylor MD, Jefferies JL, Rafael-Fortney JA, Lowe J, Roble SL, Cripe LH. Raman SV, et al. Lancet Neurol. 2015 Feb;14(2):153-61. doi: 10.1016/S1474-4422(14)70318-7. Epub 2014 Dec 30. Lancet Neurol. 2015. PMID: 25554404 Free PMC article. Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Health Information